Skip to main content
Clinical Trials/NL-OMON48065
NL-OMON48065CompletedNot Applicable

The Role of microbial produced ethanol in etiology of Non-Alcoholic Steatohepatitis (ETHANASH trial) - ETHANASH trial

Academisch Medisch Centrum0 sites20 target enrollmentStarted: TBDLast updated:
Conditions

Trial Snapshot

Phase
Not Applicable
Status
Completed
Enrollment
20

Study Overview

Brief Summary

No summary available.

Study Design

Study Type
Observational

Eligibility Criteria

Ages
18 to 64 (—)

Inclusion Criteria

  • - Diagnosis of NASH on liver biopsy taken on clinical grounds at the outpatient
  • - 18-65 years of age
  • - BMI > 25 kg/m2
  • - Subjects should be able to give informed consent,
  • Healthy controls:
  • - BMI >25 kg/m2
  • - 18-65 years of age
  • - Subjects should be able to give informed consent

Exclusion Criteria

  • - Primary lipid disorder
  • - Known genetic basis for insulin resistance or glucose intolerance
  • - Ethanol intake
  • - Pregnancy, females who are breastfeeding
  • - Hepatitis B and/or C
  • - Auto-immune hepatitis
  • - Wilson disease/ alpha 1-antitripsine deficiency
  • - Hemochromatosis
  • - Use of drugs interacting with Fomepizole (products requiring CYP2E1 for
  • metabolizing).
  • - Use of drugs interacting with Clindamycine, metronidazole or ciprofloxacin.

Investigators

Similar Trials